Dec 31, 2012

United Therapeutics Q4 2012 Earnings Report

Total Revenue
$244M
Previous year: $195M
+24.9%
EPS
$2.5
Previous year: $0.8
+212.5%
Gross Profit
$206M
Previous year: $170M
+21.4%
Cash and Equivalents
$159M
Previous year: $168M
-5.1%
Free Cash Flow
$84M
Previous year: $52.4M
+60.3%
Total Assets
$1.63B
Previous year: $1.52B
+7.1%

United Therapeutics

United Therapeutics